RT Journal Article
SR Electronic
T1 673 FIERCE-HN: a multicenter, randomized, placebo-controlled, phase 3 study of ficlatuzumab + cetuximab in pts w/recurrent or metastatic (R/M) HPV-negative head and neck squamous cell carcinoma (HNSCC)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A763
OP A763
DO 10.1136/jitc-2023-SITC2023.0673
VO 11
IS Suppl 1
A1 Bauman, Julie E
A1 Kasturi, Vijay
A1 Birkhofer, Martin
A1 Haddad, Robert
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A763.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.